%0 Journal Article
%T CT Appearance Following Partial Nephrectomy for Renal Cell Carcinoma Using Tissue Adhesive Bioglue
%A Simona Croituro
%A Yair Braz
%A Boaz Moskovitz
%A Ofer Nativ
%A Sarel Halachmi
%J Open Journal of Urology
%P 75-79
%@ 2160-5629
%D 2013
%I Scientific Research Publishing
%R 10.4236/oju.2013.32015
%X <p class=\"MsoNormal\">
	<b><span lang=\"EN-US\">Background: </span></b><span lang=\"EN-US\">The use of
biological sealants has greatly increased during nephron sparing surgery. In
many cases the bulk of the material was erroneously mistaken for tumor
recurrence.</span><span lang=\"EN-US\"> </span><b><span lang=\"EN-US\">Objective</span></b><b><span lang=\"EN-US\">:</span></b><span lang=\"EN-US\"> To describe the characteristic appearance
of biological adhesive material used for tumor bed closure on computerized
tomography (CT) following nephrone sparing surgery (NSS) for renal cell
carcinoma, in order to differentiate between typical features of the adhesive
material and local tumor recurrence.</span><span lang=\"EN-US\"> </span><b><span lang=\"EN-US\">Design, Setting and Participants:</span></b><span lang=\"EN-US\"> We retrospectively reviewed follow</span><span lang=\"EN-US\">-</span><span lang=\"EN-US\">up CT scans of 120
patients who underwent NSS for T1N<st1:chmetcnv tcsc=\"0\" numbertype=\"1\" negative=\"False\" hasspace=\"False\" sourcevalue=\"0\" unitname=\"m\" w:st=\"on\">0M</st1:chmetcnv>0
RCC. In all cases tumor bed was closed during surgery with biological tissue
adhesive (BioGlue). <b>Results and Limitations:</b> During 1994-2009</span><span lang=\"EN-US\">,</span><span lang=\"EN-US\"> 120
patients with a single T1 renal cell carcinoma lesion, underwent NSS with closure
of tumor bed with bio adhesive material. There were 66 males and 47 females
with mean age of 58.7 years (median: 58 years, range: 28</span><span lang=\"EN-US\"> - </span><span lang=\"EN-US\">85
years). Mean follow</span><span lang=\"EN-US\">-</span><span lang=\"EN-US\">up time was 45</span><span lang=\"EN-US\"> </span><span lang=\"EN-US\">¡À</span><span lang=\"EN-US\"> </span><span lang=\"EN-US\">34 months (median 42, range 12</span><span lang=\"EN-US\"> </span><span lang=\"EN-US\">-</span><span lang=\"EN-US\"> </span><span lang=\"EN-US\">168).
During follow</span><span lang=\"EN-US\">-</span><span lang=\"EN-US\">up, 3 patients had local recurrence at the site of previous
enucleated lesion. In the first post-operative CT scan the BG appeared as a
heterogeneous mass with sharp edges measuring 20</span><span lang=\"EN-US\"> </span><span lang=\"EN-US\">-</span><span lang=\"EN-US\"> </span><span lang=\"EN-US\">70 HU
with no attenuation following the injection of contrast material. In subsequent
follow-up scans the BG in most patients remained stable in size; in few patients
slight reduction in size was observed probably due to the resolution of
post-operative hematoma. Tumor
%K CT
%K RCC
%K Tissue Adhesive Bioglue
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=31325